Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.

导出 OA

翻译打印收藏纠错

第一作者： Natalie,Reizine

第一单位： Section of Geriatric and Palliative Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois, USA.

作者： Natalie,Reizine ^[1] ; Keith,Danahey ^[2] ; Emily,Schierer ^[2] ; Ping,Liu ^[3] ; Merisa,Middlestadt ^[2] ; Jenna,Ludwig ^[4] ; Tien M,Truong ^[2] ; Xander M R,van Wijk ^[2] ; Kiang-Teck J,Yeo ^[1] ; Monica,Malec ^[2] ; Mark J,Ratain ^[5] ; Peter H,O'Donnell ^[2]

作者单位： Section of Geriatric and Palliative Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois, USA. ^[1] Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois, USA. ^[2] Center for Research Informatics, University of Chicago, Chicago, Illinois, USA. ^[3] Department of Public Health Services, University of Chicago, Chicago, Illinois, USA. ^[4] Department of Pathology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois, USA. ^[5] Section of Geriatric and Palliative Medicine, Department of Medicine, University of Chicago, Chicago, Illinois. ^[6]

关键词 Cancer Oncology Opioids Pain Pharmacogenomics

主题词镇痛药, 阿片类(Analgesics, Opioid);细胞色素P450 CYP2D6(Cytochrome P-450 CYP2D6);人类(Humans);肿瘤(Neoplasms);疼痛(Pain);遗传药理学(Pharmacogenetics)

DOI 10.1002/onco.13953

PMID 34423496

发布时间 2021-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交